These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37133710)

  • 1. N-substituted tetrahydro-beta-carboline as mu-opioid receptors ligands: in silico study; molecular docking, ADMET and molecular dynamics approach.
    Alananzeh WA; Al-Qattan MN; Ayipo YO; Mordi MN
    Mol Divers; 2024 Jun; 28(3):1273-1289. PubMed ID: 37133710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.
    Wang H; Reinecke BA; Zhang Y
    J Comput Aided Mol Des; 2020 Aug; 34(8):879-895. PubMed ID: 32193867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Structural Requirements of N-Substituted Tetrahydro-β-Carboline Imidazolium Salt Derivatives Using in Silico Approaches for Designing MEK-1 Inhibitors.
    Liang J; Wang M; Li X; He X; Cao C; Meng F
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
    Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
    Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand based conformational space studies of the μ-opioid receptor.
    Sena DM; Cong X; Giorgetti A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand interaction, binding site and G protein activation of the mu opioid receptor.
    Cui X; Yeliseev A; Liu R
    Eur J Pharmacol; 2013 Feb; 702(1-3):309-15. PubMed ID: 23415745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.
    Noha SM; Schmidhammer H; Spetea M
    ACS Chem Neurosci; 2017 Jun; 8(6):1327-1337. PubMed ID: 28125215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists.
    Dumitrascuta M; Ben Haddou T; Guerrieri E; Noha SM; Schläfer L; Schmidhammer H; Spetea M
    J Med Chem; 2017 Nov; 60(22):9407-9412. PubMed ID: 29053268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free cell phenotypic study of opioid receptors and discovery of novel mu opioid ligands from natural products.
    Hou T; Xu F; Peng X; Zhou H; Zhang X; Qiu M; Wang J; Liu Y; Liang X
    J Ethnopharmacol; 2021 Apr; 270():113872. PubMed ID: 33485984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation.
    Jiang X; Li S; Zhang H; Wang LL
    Comput Biol Chem; 2021 Feb; 90():107405. PubMed ID: 33184004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.
    Weltrowska G; Lemieux C; Chung NN; Guo JJ; Wilkes BC; Schiller PW
    Bioorg Med Chem; 2014 Sep; 22(17):4581-6. PubMed ID: 25129170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Chem Inf Model; 2015 Nov; 55(11):2421-34. PubMed ID: 26517559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How μ-opioid receptor recognizes fentanyl.
    Vo QN; Mahinthichaichan P; Shen J; Ellis CR
    Nat Commun; 2021 Feb; 12(1):984. PubMed ID: 33579956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways.
    Schneider S; Provasi D; Filizola M
    Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.
    Yuan Y; Zaidi SA; Stevens DL; Scoggins KL; Mosier PD; Kellogg GE; Dewey WL; Selley DE; Zhang Y
    Bioorg Med Chem; 2015 Apr; 23(8):1701-15. PubMed ID: 25783191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators.
    Wang H; Cao D; Gillespie JC; Mendez RE; Selley DE; Liu-Chen LY; Zhang Y
    Future Med Chem; 2021 Mar; 13(6):551-573. PubMed ID: 33590767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biochemical evaluation of 17-N-beta-aminoalkyl-4,5α-epoxynormorphinans.
    Ötvös F; Szűcs E; Urai Á; Köteles I; Szabó PT; Varga ZK; Gombos D; Hosztafi S; Benyhe S
    Sci Rep; 2023 Nov; 13(1):20305. PubMed ID: 37985681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.
    Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Nilsen A; Torralva R; Janowsky A
    Biochem Pharmacol; 2020 Dec; 182():114293. PubMed ID: 33091380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt
    Dumitrascuta M; Bermudez M; Ballet S; Wolber G; Spetea M
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32365707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.